Startup Funding News

Explore funding rounds, the companies behind them and the investors taking part.

Rounds: 8
Disclosed funding: $852.9M
Median round: $200M

Funding rounds
Company	Amount	Round	Sector	Country	Investors	Announced
ST Star TherapeuticsBiotech · United StatesCompany profile Biotechnology company discovering and developing antibody therapies for diseases with significant unmet need. Biotechnology company discovering and developing antibody therapies for diseases with significant unmet need.	$200M	Private financingUndisclosed	Biotech	United States	Investors Janus Henderson InvestorsLead OrbiMedLead	Oct 23
PA Pathos AIBiotech · United StatesCompany profile Clinical-stage drug developer using AI to select therapeutic assets and guide oncology trials. Clinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.	$237M	Series ESeries C+	Biotech	United States	Investors Bristol Myers SquibbLead	Oct 23
WS Warp SciencesBiotech · United StatesCompany profile Warp Sciences combines chemistry, AI and robotics to help drug discovery teams make and test molecules in the United States. Warp Sciences combines chemistry, AI and robotics to help drug discovery teams make and test molecules in the United States.	$215M	Series A	Biotech	United States	Investors LightspeedLead IVP +4 Lux Capital Mayfield Menlo Ventures Premji Invest	Oct 22
S SEGNOSBiotech · JapanCompany profile SEGNOS develops magnetic-particle materials and diagnostic technologies for blood testing. SEGNOS develops magnetic-particle materials and diagnostic technologies for blood testing.	Undisclosed	Pre-Series AUndisclosed	Biotech	Japan	Investors TUAT1号投資事業有限責任組合	Oct 22
i iCUREXHealthtech · JapanCompany profile Kagoshima medical-device company developing chitosan hydrogel materials for wound care, including the syringe-delivered Kitosla CX dressing. Kagoshima medical-device company developing chitosan hydrogel materials for wound care, including the syringe-delivered Kitosla CX dressing.	¥140M	Series A first close: equity and debtSeries A	Biotech, Healthtech	Japan	Investors NCB Venture CapitalLead Green Core +2 INDEP Japan Finance Corporation	Oct 22
W WarhoundDefense tech · United StatesCompany profile Warhound develops working dogs for military, law-enforcement and emergency-response teams. Warhound develops working dogs for military, law-enforcement and emergency-response teams.	$200M	Seed	Biotech, Defense tech	United States	Investors 8VC ARK Invest +10 Breyer Capital Builders VC CAZ Investments Franklin Templeton In-Q-Tel Lux Capital Neogenesis Robert Nelsen Sequoia Capital US Innovative Technology Fund (USIT)	Oct 22
K KinishFoodtech · JapanCompany profile Rice-based dairy alternatives and plant molecular-farming technology. Rice-based dairy alternatives and plant molecular-farming technology.	¥490M	Series A first closeSeries A	Biotech, Foodtech	Japan	Investors INSPiRE Mutualistic Symbiosis Fund 1 Love Veggies Holding Ltd. +2 Obayashi Corporation Shimadzu Future Innovation Fund	Oct 20
N NouscomBiotech · SwitzerlandCompany profile Clinical-stage biotech developing neoantigen-based cancer immunotherapies. Clinical-stage biotech developing neoantigen-based cancer immunotherapies.	€120M	Series DSeries C+	Biotech	Switzerland	Investors M VenturesLead Revelation PartnersLead +13 5AM Ventures Andera Partners Angelini Investments Angelini Ventures Bpifrance CDP Venture Capital EQT Life Sciences European Investment Bank Indaco Ventures SGR Neva SGR Panakès Partners Versant Ventures Xgen Ventures	Oct 19